Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Cardiovascular Function and Risk Factors, Cardiac Imaging and Diagnostics, Atrial Fibrillation Management and Outcomes, and Cardiovascular Disease and Adiposity.
Prognostic Relevance and Lower Limit of the Reference Range of Left Ventricular Global Longitudinal Strain
Infectious diseases, cardio-cerebrovascular health and vaccines: pathways to prevention
A Nationwide Factorial Randomized Trial of Electronic Nudges to Patients With Chronic Kidney Disease and Their General Practices for Increasing Guideline-Directed Medical Therapy: The NUDGE-CKD Trial
Cardiovascular-Focused Messaging to Improve Influenza Vaccination Rates
Digital Nudges to Increase Influenza Vaccination in Patients with Chronic Diseases
Electronic nudges to increase influenza vaccination uptake in younger and middle-aged individuals with atrial fibrillation: a prespecified analysis of the NUDGE-FLU-CHRONIC trial
Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Diseases
Tricuspid Regurgitation and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction
Electronic nudges for sustained influenza vaccination uptake in older adults: the nationwide randomized NUDGE-FLU-2 trial
Rationale and design of NUDGE-FLU-CHRONIC and NUDGE-FLU-2: Two nationwide randomized trials of electronic nudges to increase influenza vaccination among patients with chronic diseases and older adults during the 2023/2024 influenza season
Electronic Nudges and Influenza Vaccination Among Patients With a History of Myocardial Infarction
Electronic Nudge Letters to Increase Influenza Vaccination Uptake in Younger and Middle-Aged Individuals With Diabetes
Lifestyle habits associated with cardiac conduction disease
Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort project
Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF
The significance of left ventricular ejection time in heart failure with reduced ejection fraction
All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study
Heart Failure in COVID-19: The Multicentre, Multinational PCHF-COVICAV Registry
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people
Omecamtiv Mecarbil in Chronic Heart Failure with Reduced Ejection Fraction: GALACTIC-HF Baseline Characteristics and Comparison with Contemporary Clinical Trials
Multicentric Atrial Strain COmparison between Two Different Modalities: MASCOT HIT Study
Cardiovascular comorbidities as predictors for severe COVID-19 infection or death
Machine Learning-Based Phenogrouping in Heart Failure to Identify Responders to Cardiac Resynchronization Therapy
Prognostic Importance of Left Ventricular Mechanical Dyssynchrony in Heart Failure with Preserved Ejection Fraction
Global Electric Heterogeneity Risk Score for Prediction of Sudden Cardiac Death in the General Population
Contemporary Assessment of Left Ventricular Diastolic Function in Older Adults
Global Longitudinal Strain Is a Superior Predictor of All-Cause Mortality in Heart Failure With Reduced Ejection Fraction